Global Cancer Diagnostics Market is Expected to Reach USD 232.7 Billion by 2025 - Reuters

 

Global Cancer Diagnostics Market is Expected to Reach USD 232.7 Billion by 2025

Global Cancer Diagnostics Market is Expected to Reach USD 232.7 Billion by 2025

Fri Apr 21, 2017 - 10:30am UTC

OrbisResearch.com has published new research report on “Cancer Diagnostics Market Analysis By Type (Laboratory Tests, Genetic Tests, Imaging, Endoscopy), By Application (Breast, Lung, Liver, Cervical, Colorectal, Skin), By Region, And Segment Forecasts 2025” to its database.

Global Cancer Diagnostics Market is Expected to Reach USD 232.7 Billion by 2025

Dallas, United States – April 21, 2017

The global cancer diagnostics market is expected to reach USD 232.7 billion by 2025, according to a new report by Grand View Research, Inc. Continual introduction of innovative products coupled with increasing need for early diagnosis of the disease is the prime factor driving the market growth. In addition, rapid growth of the sector is attributed to the penetration of technologically advanced laboratory systems that have improved oncological screening in yielding accurate outcomes. Rising incidence of cancer is triggering the demand for these screening tests and imaging modalities that are used for monitoring disease progression.

Browse the report: http://www.orbisresearch.com/reports/index/cancer-diagnostics-market-analysis-by-type-laboratory-tests-genetic-tests-imaging-endoscopy-by-application-breast-lung-liver-cervical-colorectal-skin-by-region-and-segment-forecasts-2014-2025
Collaborative and independent initiatives led by governments and companies are striving to raise cognizance about the benefits of early diagnosis of the disease. In addition, cancer research organizations along with public and private entities are investing heavily on research projects to launch advanced diagnostic tools in the market, which are capable of diagnosing the disease way before the symptoms appear.

Furthermore, giant players are collaborating with governments and other agencies to enhance patient accessibility of their products. For instance, Illumina, Inc. launched a new venture named GRAIL with investors, Jeff Bezos and Bill Gates, with an investment of more than $100 million. GRAIL is mainly focused on blood-based oncological screening for timely diagnosis of the most common tumor types through simple laboratory tests.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/267654

Further Key Findings from the Study Suggest:
Rapid adoption of technology and escalating need for early diagnosis is augmenting the growth of the imaging systems space. Thus, the segment is expected to grow at the fastest CAGR at over 8.0% during the forecast period.

The breast cancer segment, among other application segments, accounted for the largest share due to the high incidence rate of breast cancer triggering the need for its early diagnosis.

In 2016, North America dominated the global space with the largest revenue share of more than 41%. Focused research efforts in oncology for the development of early tumor detection tools coupled with grants from government healthcare agencies are contributing to a strong medical ecosystem to fight cancer in this region.

Buy the report@http://www.orbisresearch.com/contact/purchase/267654

Asia Pacific is expected to emerge as the fastest growing region during the forecast period. The growing patient pool in India, China, and Japan; due to the support in diagnostic process at comparatively lower prices; and a favorable regulatory framework are some of the factors boosting the market growth in this region.

Major players competing in this market include GE Healthcare; Abbott; Hoffmann-La Roche Ltd and Siemens Healthcare GmbH. Other prominent players operating in the market include but are not limited to Becton Dickinson & Company; Illumina, Inc.; Koninklijke Philips N.V.; and Hologic, Inc.

Major Points From Table Of Contents:
Chapter One: Research Methodology
Chapter Two: Executive Summary
Chapter Three: Cancer Diagnostics Market Variables, Trends & Scope
Chapter Four: Cancer Diagnostics: Screening Type Estimates & Trend Analysis
Chapter Five: Cancer Diagnostics: Application Estimates & Trend Analysis
Chapter Six: Cancer Diagnostics: Regional Estimates &Trend Analysis, by Screening Type & Application Type
Chapter Seven: Competitive Landscape

List of Figures
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Penetration & Growth prospect mapping
FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Cancer Diagnostics Market product outlook key takeaways
FIG. 16 Cancer Diagnostics: Screening Type movement analysis
FIG. 17 Laboratory Tests Market, 2014 – 2025 (USDBillion)
FIG. 18 Genetic Tests Market, 2014 – 2025 (USD Billion)
FIG. 19 Imaging Market, 2014 – 2025 (USD Billion)
FIG. 20 Endoscopy Market, 2014 – 2025 (USD Billion)

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Info:
Name: Hector Costello
Email: sales@orbisresearch.com
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600, Dallas, Texas – 75204, U.S.A.
Phone: +1 (214) 884-6817

For content enquiry, please reach us at

Latest News >

Vertex Ventures to co-lead US$11 million round in Israeli transcription startup Verbit

Verbit uses AI to combine software with human transcribers to improve quality, speed and price of services.

06:29am UTC

Indonesia’s Electronic Signature Startup PrivyID secures US$5 million in Series A

PrivyID is Indonesia’s DocuSign and it enables users and enterprises to digitally sign and transfer document online with an integrated audit trailer.

05:03am UTC

Online Content Marketplace GetCRAFT in talks to raise US$5 million Series A by 2018

GetCRAFT is an online content marketplace, which connects brands and agencies in Southeast Asia with content creators and marketers across the globe.

05:05am UTC

Malaysian wealth fund Khazanah to buy Prince Court Medical Centre from Petronas

OrbisResearch.com has published new research report on “Cancer Diagnostics Market Analysis By Type (Laboratory Tests, Genetic Tests, Imaging, Endoscopy), By Application (Breast, Lung, Liver, Cervical, Colorectal, Skin), By Region, And Segment Forecasts 2025” to its database. Dallas, United States – April 21, 2017 — The global cancer diagnostics market is expected to reach USD 232.7 […]

06:57am UTC

VinaCapital to invest US$10 million in Vietnamese real estate firm Ricons

VinaCapital said the investment is in line with the company’s strategy to invest in company benefiting from strong domestic growth.

05:03am UTC